Tag Archives: Birth control

Featured Stories
British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Premarket Approval for Essure Birth Control Device Was Fraudulent, Patients Say

premarket-approval-Essure

Patients involved in the clinical trials conducted in connection with the premarket approval application (PMA) for the Essure birth control device say that patient records were altered to show favorable results despite patient reports of problems. The Food and Drug … Continue reading

Posted in Defective Medical Devices, Essure, Health Concerns | Tagged , , , , |

Legislation Introduced to Require FDA to Pull Essure Birth Control from Market

FDA to Pull Essure Birth Control from Market

U.S. Representative Michael Fitzpatrick of Pennsylvania has introduced a new bill that directs the Food and Drug Administration (FDA) to withdraw Bayer’s Essure birth control implant from the market. The safety of the implantable device—a permanent birth control method—has been … Continue reading

Posted in Defective Medical Devices, Essure, Health Concerns | Tagged , , , , |

FDA Convening Panel to Reconsider Safety of Essure Birth Control System

FDA Convening Panel to Reconsider Safety of Essure

On September 24, 2015, the Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration (FDA) will meet to discuss the risks and benefits of Bayer HealthCare’s Essure birth control system. The panel … Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , |

In Light of Patient Complaints, FDA to Reconsider Safety of Essure Permanent Birth Control

FDA to Reconsider Safety of Essure Permanent Birth Control

The U.S. Food and Drug Administration (FDA) will be re-evaluating the safety of Essure following complaints from patients who say the permanent birth control device caused painful complications. Currently, it is the only approved permanent nonsurgical form of contraception on … Continue reading

Posted in Legal News | Tagged , , , , |

Thousands of Complaints Prompt FDA Panel Meeting about Essure Birth Control

Complaints Prompt FDA Panel Meeting about Essure

In response to more than 5,000 reports of adverse events and side effects of the Essure birth control implant, the Food and Drug Administration (FDA) has scheduled a hearing for September 24 to evaluate the safety and effectiveness device. The … Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , |

Study Links Newer Birth Control Pills to Increased Risk of Blood Clots

Newer Birth Control Pills to Increased Risk of Blood Clots

A study published in the BMJ, the online journal of the British Medical Association, adds to a growing body of evidence linking newer birth control pills to an increased risk of blood clots. Researchers found that women taking newer oral … Continue reading

Posted in Health Concerns, Legal News | Tagged , , , , |

Food and Drug Administration Issues Response to Petition for Removal of Essure Birth Control from Market

FDA Issues Response to Petition for Removal of Essure Birth Control from Market

Last week the Food and Drug Administration (FDA) responded to a petition demanding removal of Essure permanent birth control device from the market. The petition was signed by more than 2,100 women who are concerned about injuries and adverse effects … Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , |

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors. Hormonal contraceptives, which contain female sex hormones, are commonly prescribed in pill form. “The Pill” first … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

Birth Control Shot Depo-Provera may Increase HIV Risk

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection. The study was conducted by researchers at the University of California at Berkeley and published in The … Continue reading

Posted in Legal News | Tagged , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.